220299-99-0

Basic information

• Product Name: Acetic acid, [4-(acetylamino)phenoxy]-, methyl ester
• CAS NO: 220299-99-0
• Molecular Formula: C11H13NO4
• Molecular Weight: 223.229
• Mol File: 220299-99-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Acetic acid, [4-(acetylamino)phenoxy]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, [4-(acetylamino)phenoxy]-, methyl ester(220299-99-0)
• EPA Substance Registry System: Acetic acid, [4-(acetylamino)phenoxy]-, methyl ester(220299-99-0)

Safety Data

• Hazardous Substances Data: 220299-99-0(Hazardous Substances Data)

Upstream product

• 19786-48-2 methyl 2-(4-nitrophenoxy)acetate 
• 108-24-7 acetic anhydride 
• 103-90-2 4-acetaminophenol 
• 96-34-4 methyl chloroacetate 
• 96-32-2 bromoacetic acid methyl ester 

Downstream Products

• 77068-94-1 N-{4-[(5-sulfanyl-1,3,4-oxadiazol-2-yl)methoxy]phenyl}acetamide 
• 75129-75-8 N‐(4‐(2‐hydrazinyl‐2‐oxoethoxy)phenyl) acetamide 
• 47243-39-0 2-(4-acetylaminophenoxy)-N-(2-diethylaminoethyl)acetamide 

Relevant articles and documents

Synthesis of 1,3,4-oxadiazole derivatives with anticonvulsant activity and their binding to the GABAA receptor

In this study, a series of 1,3,4-oxadiazole derivatives (5a-s, 10a-s, and 16a-d) were designed and synthesized using maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) models, to test the anticonvulsant activity of the target compounds

Substituted piperidine compounds useful as modulators of chemokine receptor activity

The invention provides compounds of formula (I) wherein R1, R2, R3, R6, Z, Q, m, n, X1, X2, X3, X4 and T are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them, and their use in therapy, especially for the treatment of chemokine receptor related diseases and conditions